The medication, faricimab, could soon be offered to people with wet age-related macular degeneration (wet AMD), a leading cause of vision loss in over-60s, and to sufferers of diabetic macular oedema, an eye problem linked to diabetes. The Daily Mail
No comments:
Post a Comment